Insulin Pump Use Linked to High Rates of Uncontrolled Glycemic Levels: Study

Diabetics using an insulin pump may experience some health improvements, but a new British study suggests the devices are linked to poor control of blood sugar levels among patients with Type I diabetes.

In a study presented at an American Diabetes Association meeting on June 7, researchers indicate that nearly 40% of patients with Type I diabetes still had a blood sugar level over 8.5 percent while using an insulin pump.

Researchers from the University of Manchester, England, conducted a retrospective study of nearly 450 patients who were on an insulin pump for at least 12 months with glycated hemoglobin averaged over a 30 month period through November 2014.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Patients A1c, blood glucose level, was measured to identify which patients had high concentrations over prolonged periods of time.

Overall, more than one-third of patients maintained high blood glucose levels above 8.5%, while another 11%of patients using an insulin pump were above a 10% A1c level.

These proportions were seen despite an average 0.6% blood glucose improvement after starting insulin pump therapy. Researchers noted there were greater declines in patients starting at higher A1c levels..

The study is one of the largest conducted on the effectiveness of insulin pumps. Approximately 42% of patients who were studied used a Medtronic pump, 30% used Omnipod, 14% used Animas and 13% used Accu-Chek.

There was no difference in blood glucose levels when comparing different types of pumps among users. Researchers did see a negative correlation between blood glucose levels and age, but not with duration of pump use.

Less than one-third of patients achieved a good control of their blood glucose levels when using an insulin pump. That rate did improve from 19% who had their blood glucose levels under control before receiving the pump to 32% who had the levels under control after receiving the pump.

The proportion of patients above an 8.5% blood glucose levels declined from 52% to 40% overall.

Researchers say the reason for the poor outcomes may have to do with a person’s adherence to proper use guidelines or limited use with continued glucose monitoring.

Doctors hope placing a patient on an insulin pump may improve blood glucose levels, but that depends on whether the patient does the necessary things to control their blood glucose.

“Our data highlight the challenges of managing T1DM [Type 1 diabetes] in real-life conditions,” researchers concluded.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Lawsuit MDL Application Will Be Considered by JPML at Hearing on Jan. 30, 2025
Depo-Provera Lawsuit MDL Application Will Be Considered by JPML at Hearing on Jan. 30, 2025 (Posted 4 days ago)

With a growing number of women pursuing Depo-Provera brain tumor lawsuits throughout the federal court system, the U.S. JPML will decide whether to consolidate and centralize the claims before one judge for coordinated discovery and pretrial proceedings.